← Back to Search

Observational (questionnaire, biospecimen collection) for Osteosarcoma

N/A
Waitlist Available
Led By Margarett Shnorhavorian
Research Sponsored by Children's Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 years
Awards & highlights

Summary

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Follicle stimulating hormone
Infertility
Luteinizing hormone levels
+5 more
Other outcome measures
Role of genetic susceptibility in the development of impairments in spermatogenesis or steroidogenesis with contemporary regimens for the treatment of osteosarcoma

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (questionnaire, biospecimen collection)Experimental Treatment3 Interventions
Participants complete a health questionnaire over 30-45 minutes. Patients also provide saliva and semen samples and undergo collection of blood.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020

Find a Location

Who is running the clinical trial?

Children's Oncology GroupLead Sponsor
457 Previous Clinical Trials
239,606 Total Patients Enrolled
30 Trials studying Osteosarcoma
7,630 Patients Enrolled for Osteosarcoma
National Cancer Institute (NCI)NIH
13,841 Previous Clinical Trials
41,002,591 Total Patients Enrolled
104 Trials studying Osteosarcoma
16,404 Patients Enrolled for Osteosarcoma
Margarett ShnorhavorianPrincipal InvestigatorChildren's Oncology Group
~29 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top